Additionally, NDC-011, a novel drug combination developed through DR.NOAH's AI-based drug discovery platform, received Orphan Drug Designation (ODD) from the U.S. FDA in 2023 and IND approval for a ...
ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...
News-Medical.Net on MSN
Machine learning models can help diagnose ALS earlier from a blood sample
Using machine learning models, researchers at Michigan Medicine have identified a potential way to diagnose amyotrophic ...
PRESS RELEASEAB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV HIGHLIGHTING CLINICAL BENEFIT WITH MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS ...
In addition to ALS, pridopidine is in late-stage clinical development for HD, with Prilenia and Ferrer planning to initiate a confirmatory study in HD designed to confirm pridopidine's effects and ...
Expansion in Asia-Pacific with second subsidiary, following Australia, pivotal to enrolling patients in phase II trial ...
Just 3 disease-modifying treatments—edaravone, riluzole, and sodium phenylbutyrate and taurursodiol (PB/TURSO)—are currently FDA approved to slow progression of amyotrophic lateral sclerosis (ALS). A ...
COVERING YOUR COMMUNITY. PEOPLE IN BOYNTON BEACH CAME TOGETHER YESTERDAY TO CELEBRATE A GOOD CAUSE. OUR MORNING ANCHOR TRAFFIC ANCHOR YASMINE JULMISSE EMCEED THE 2024 WALK TO DEFEAT ALS, CELEBRATING ...
McCormick played a key role passing Gov. Bill Haslam's Tennessee Promise bill, which offers two-year degrees tuition-free to ...
The upcoming book will be titled Book of Days: A Memoir in Moments, coming out in 2026. Along with his ALS battle, Dane's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback